By Alicia Ault WASHINGTON (Reuters Health) Oct 03 –
A panel of US government advisers on Thursday called for more protections for people who participate in clinical trials, including establishing a central federal panel to oversee all public and private research.
The Institute of Medicine (IOM) committee began an investigation of research protections after the 1999 death of Jesse Gelsinger, a participant in a gene therapy study at the University of Pennsylvania. After 18 months, the panel concluded that a new system needs to be established to help restore public faith in the clinical trial process.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!